Cargando…

Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants

Ranunculales, comprising of 7 families that are rich in medicinal species frequently utilized by traditional medicine and ethnomedicine, represents a treasure chest of biodiversity and chemodiversity. The phylogenetically related species often have similar chemical profile, which makes them often po...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Da-cheng, Xu, Li-jia, Zheng, Yu-wei, Lyu, Huai-yu, Xiao, Pei-gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282152/
https://www.ncbi.nlm.nih.gov/pubmed/35809180
http://dx.doi.org/10.1007/s11655-022-3576-x
_version_ 1784747046658375680
author Hao, Da-cheng
Xu, Li-jia
Zheng, Yu-wei
Lyu, Huai-yu
Xiao, Pei-gen
author_facet Hao, Da-cheng
Xu, Li-jia
Zheng, Yu-wei
Lyu, Huai-yu
Xiao, Pei-gen
author_sort Hao, Da-cheng
collection PubMed
description Ranunculales, comprising of 7 families that are rich in medicinal species frequently utilized by traditional medicine and ethnomedicine, represents a treasure chest of biodiversity and chemodiversity. The phylogenetically related species often have similar chemical profile, which makes them often possess similar therapeutic spectrum. This has been validated by both ethnomedicinal experiences and pharmacological investigations. This paper summarizes molecular phylogeny, chemical constituents, and therapeutic applications of Ranunculales, i.e., a pharmacophylogeny study of this representative medicinal order. The phytochemistry/metabolome, ethnomedicine and bioactivity/pharmacology data are incorporated within the phylogenetic framework of Ranunculales. The most studied compounds of this order include benzylisoquinoline alkaloid, flavonoid, terpenoid, saponin and lignan, etc. Bisbenzylisoquinoline alkaloids are especially abundant in Berberidaceae and Menispermaceae. The most frequent ethnomedicinal uses are arthritis, heat-clearing and detoxification, carbuncle-abscess and sore-toxin. The most studied bioactivities are anticancer/cytotoxic, antimicrobial, and anti-inflammatory activities, etc. The pharmacophylogeny analysis, integrated with both traditional and modern medicinal uses, agrees with the molecular phylogeny based on chloroplast and nuclear DNA sequences, in which Ranunculales is divided into Ranunculaceae, Berberidaceae, Menispermaceae, Lardizabalaceae, Circaeasteraceae, Papaveraceae, and Eupteleaceae families. Chemical constituents and therapeutic efficacy of each taxonomic group are reviewed and the underlying connection between phylogeny, chemodiversity and clinical uses is revealed, which facilitate the conservation and sustainable utilization of Ranunculales pharmaceutical resources, as well as developing novel plant-based pharmacotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material (Appendixes 1–9) is available in the online version of this article at 10.1007/s11655-022-3576-x.
format Online
Article
Text
id pubmed-9282152
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-92821522022-07-15 Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants Hao, Da-cheng Xu, Li-jia Zheng, Yu-wei Lyu, Huai-yu Xiao, Pei-gen Chin J Integr Med Review Ranunculales, comprising of 7 families that are rich in medicinal species frequently utilized by traditional medicine and ethnomedicine, represents a treasure chest of biodiversity and chemodiversity. The phylogenetically related species often have similar chemical profile, which makes them often possess similar therapeutic spectrum. This has been validated by both ethnomedicinal experiences and pharmacological investigations. This paper summarizes molecular phylogeny, chemical constituents, and therapeutic applications of Ranunculales, i.e., a pharmacophylogeny study of this representative medicinal order. The phytochemistry/metabolome, ethnomedicine and bioactivity/pharmacology data are incorporated within the phylogenetic framework of Ranunculales. The most studied compounds of this order include benzylisoquinoline alkaloid, flavonoid, terpenoid, saponin and lignan, etc. Bisbenzylisoquinoline alkaloids are especially abundant in Berberidaceae and Menispermaceae. The most frequent ethnomedicinal uses are arthritis, heat-clearing and detoxification, carbuncle-abscess and sore-toxin. The most studied bioactivities are anticancer/cytotoxic, antimicrobial, and anti-inflammatory activities, etc. The pharmacophylogeny analysis, integrated with both traditional and modern medicinal uses, agrees with the molecular phylogeny based on chloroplast and nuclear DNA sequences, in which Ranunculales is divided into Ranunculaceae, Berberidaceae, Menispermaceae, Lardizabalaceae, Circaeasteraceae, Papaveraceae, and Eupteleaceae families. Chemical constituents and therapeutic efficacy of each taxonomic group are reviewed and the underlying connection between phylogeny, chemodiversity and clinical uses is revealed, which facilitate the conservation and sustainable utilization of Ranunculales pharmaceutical resources, as well as developing novel plant-based pharmacotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material (Appendixes 1–9) is available in the online version of this article at 10.1007/s11655-022-3576-x. Springer Nature Singapore 2022-07-09 2022 /pmc/articles/PMC9282152/ /pubmed/35809180 http://dx.doi.org/10.1007/s11655-022-3576-x Text en © The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Hao, Da-cheng
Xu, Li-jia
Zheng, Yu-wei
Lyu, Huai-yu
Xiao, Pei-gen
Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants
title Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants
title_full Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants
title_fullStr Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants
title_full_unstemmed Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants
title_short Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants
title_sort mining therapeutic efficacy from treasure chest of biodiversity and chemodiversity: pharmacophylogeny of ranunculales medicinal plants
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282152/
https://www.ncbi.nlm.nih.gov/pubmed/35809180
http://dx.doi.org/10.1007/s11655-022-3576-x
work_keys_str_mv AT haodacheng miningtherapeuticefficacyfromtreasurechestofbiodiversityandchemodiversitypharmacophylogenyofranunculalesmedicinalplants
AT xulijia miningtherapeuticefficacyfromtreasurechestofbiodiversityandchemodiversitypharmacophylogenyofranunculalesmedicinalplants
AT zhengyuwei miningtherapeuticefficacyfromtreasurechestofbiodiversityandchemodiversitypharmacophylogenyofranunculalesmedicinalplants
AT lyuhuaiyu miningtherapeuticefficacyfromtreasurechestofbiodiversityandchemodiversitypharmacophylogenyofranunculalesmedicinalplants
AT xiaopeigen miningtherapeuticefficacyfromtreasurechestofbiodiversityandchemodiversitypharmacophylogenyofranunculalesmedicinalplants